Kopin to Present Advanced Spatial Light Modulators and Microdisplays at Laser World of Photonics 2025 Kopin Corporation (NASDAQ: KOPN), a leading provider of application-specific optical systems and high-performance microdisplays for…
NEL Animal Cardiovascular Center, a private 24-hour animal hospital in South Korea, said that its cardiac surgery team has successfully performed the world’s first surgical correction of a complex ventricular…
Alcon (SIX/NYSE: ALC), the global eye care leader dedicated to helping people see with clarity, today announced the approval of the Clareon MD PanOptix MD Pro intraocular lens (IOL) for cataract patients in…
Invivoscribe is pleased to announce that the NPM1 MRD Assay developed by its wholly owned subsidiary, the Laboratory for Personalized Molecular Medicine ® (LabPMM), has been approved by the State of New York. This approval…
The HRT Club, a leading pioneer of direct-to-consumer hormone replacement therapies, today announced a strategic partnership with Posterity Health, the leader in expert-led, comprehensive men’s health. Together, the two companies are…
MediStreams and Availity® Celebrate 10 Years of Innovation, Automating $61 Billion in Healthcare Revenue Cycle Payments MediStreams, a leader in revenue cycle remittance automation, and Availity, the nation’s largest dual-sided…
Abstractive Health has launched Clinical Time Machine, an AI-driven simulation that immerses physicians in diagnostic cases using real historical medical charts. Built on the same HIPAA-compliant platform that powers live summarization…
Stanford Health Care, one of the nation’s leading academic medical centers, tapped Kivo Health as part of a collaboration to advance AI-powered virtual pulmonary rehabilitation and care for patients with…
Diffuse Bio, a leading provider of AI systems for designing protein therapeutics, today announced the public launch of DSG2-mini, its latest AI model, now accessible to researchers worldwide through DiffuseSandbox, a…
InSilicoTrials, a health tech company developing simulation-based solutions for drug development, today announced its acceptance into the Microsoft for Startups Pegasus Program, an, invitation-only initiative within Microsoft for Startups, designed to…
Capstan Therapeutics, Inc. (“Capstan”), a clinical-stage biotechnology company dedicated to advancing in vivo reprogramming of cells through RNA delivery using targeted lipid nanoparticles (tLNP), today announced successful dosing of the first participants…
Anaconda Biomed S.L., a medical technology company developing next-generation thrombectomy systems for the treatment of ischemic stroke, announced today the appointment of long-time medtech executive Charles (Chuck) Carignan, M.D., as chairman…